All News

September 27, 2023

Omniose Awarded NIH Grant of up to $3.0 Million to Develop Vaccines against Group B Streptococcus

September 27, 2023

Levine Leichtman Capital Partners Portfolio Company Technical Safety Services Acquires Controlled Environment Management

September 27, 2023

stackArmor Launches ATO for AI™ Governance Model To Help Public Sector Organizations Safely and Securely Accelerate AI Adoption

September 26, 2023

US Department of Defense Acquires Smiths Detection’s Next Generation Aerosol and Vapor Chemical Agent Detectors

September 26, 2023

908 Devices Enters Initial Production Phase of US Department of Defense Aerosol and Vapor Chemical Agent Detector Program

September 26, 2023

Booz Allen Doubles Down on Adversarial AI Capabilities With New Investment

September 25, 2023

Cadence AI-Powered Virtuoso Studio Supports RF and mmWave Design Reference Flows for TSMC N16RF, N6RF and N4PRF

September 25, 2023

The Global Healthy Living Foundation Partners with Darna Center: An Initiative to Improve Gender, Race, and Health Equity for Women in North Western and Eastern Africa

September 25, 2023

genXtraits Inc. Announces Its License of Technology for Improved Crop Nutrition

September 22, 2023

Alzamend Neuro Granted Extension by Nasdaq Panel to Regain Compliance with the Minimum Bid Price Continued Listing Requirement

September 22, 2023

Coya Therapeutics Licenses Exclusive Worldwide rights to Exosome Engineering Technology (EET) from Carnegie Mellon University (CMU)

September 22, 2023

Ligand’s Partner Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze® (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Business & Leadership